BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: Expression of the retinoid acid receptor β, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer 2005;104:1609-19. [DOI: 10.1002/cncr.21392] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Guo Z, Zhao Y, Wu Y, Zhang Y, Wang R, Liu W, Zhang C, Yang X. Cellular retinol-binding protein 1: a therapeutic and diagnostic tumor marker. Mol Biol Rep 2023;50:1885-94. [PMID: 36515825 DOI: 10.1007/s11033-022-08179-2] [Reference Citation Analysis]
2 Wang CH, Lu TJ, Wang LK, Wu CC, Chen ML, Kuo CY, Shyu RY, Tsai FM. Tazarotene-induced gene 1 interacts with Polo-like kinase 2 and inhibits cell proliferation in HCT116 colorectal cancer cells. Cell Biol Int 2021. [PMID: 34314079 DOI: 10.1002/cbin.11681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Costantini L, Molinari R, Farinon B, Merendino N. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med 2020;9:E360. [PMID: 32012980 DOI: 10.3390/jcm9020360] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
4 Shyu RY, Wang CH, Wu CC, Wang LK, Chen ML, Kuo CY, Lee MC, Lin YY, Tsai FM. Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells. Biomed Res Int 2019;2019:6171065. [PMID: 31886233 DOI: 10.1155/2019/6171065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Wang CH, Shyu RY, Wu CC, Chen ML, Lee MC, Lin YY, Wang LK, Jiang SY, Tsai FM. Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells. Mol Cells 2018;41:562-74. [PMID: 29902837 DOI: 10.14348/molcells.2018.2347] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Huebner H, Hartner A, Rascher W, Strick RR, Kehl S, Heindl F, Wachter DL, Beckmann Md MW, Fahlbusch FB, Ruebner M. Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta. Reprod Sci 2018;25:1357-70. [PMID: 29246089 DOI: 10.1177/1933719117746761] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
7 Huebner H, Strick R, Wachter DL, Kehl S, Strissel PL, Schneider-Stock R, Hartner A, Rascher W, Horn LC, Beckmann MW, Ruebner M, Fahlbusch FB. Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma. J Exp Clin Cancer Res 2017;36:165. [PMID: 29169400 DOI: 10.1186/s13046-017-0634-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
8 Shyu RY, Wang CH, Wu CC, Chen ML, Lee MC, Wang LK, Jiang SY, Tsai FM. Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192. Mol Cells 2016;39:877-87. [PMID: 27989102 DOI: 10.14348/molcells.2016.0161] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
9 He D, Zhang Y, Zhang N, Zhou L, Chen J, Jiang Y, Shao C. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein–Barr virus-associated gastric carcinomas. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0525-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
10 Hasan T, Shafi G, Grace B, Tegner J, Munshi A. DNA Methylation:: An Epigenetic Marker of Breast Cancer Influenced by Nutrients Acting as an Environmental Factor. Noninvasive Molecular Markers in Gynecologic Cancers 2015. [DOI: 10.1201/b18015-9] [Reference Citation Analysis]
11 Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53-65. [PMID: 23669186 DOI: 10.1016/j.cca.2013.05.002] [Cited by in Crossref: 228] [Cited by in F6Publishing: 211] [Article Influence: 22.8] [Reference Citation Analysis]
12 Zhang X, Li HM, Liu Z, Zhou G, Zhang Q, Zhang T, Zhang J, Zhang C. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma. J Gastroenterol 2013;48:132-43. [PMID: 22766745 DOI: 10.1007/s00535-012-0621-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
13 Duncan CG, Barwick BG, Jin G, Rago C, Kapoor-Vazirani P, Powell DR, Chi JT, Bigner DD, Vertino PM, Yan H. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res 2012;22:2339-55. [PMID: 22899282 DOI: 10.1101/gr.132738.111] [Cited by in Crossref: 131] [Cited by in F6Publishing: 138] [Article Influence: 11.9] [Reference Citation Analysis]
14 Peng Z, Shen R, Li YW, Teng KY, Shapiro CL, Lin HJ. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding. PLoS One 2012;7:e36891. [PMID: 22615834 DOI: 10.1371/journal.pone.0036891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
15 Candelaria M, de la Cruz-Hernandez E, Taja-Chayeb L, Perez-Cardenas E, Trejo-Becerril C, Gonzalez-Fierro A, Chavez-Blanco A, Soto-Reyes E, Dominguez G, Trujillo JE, Diaz-Chavez J, Duenas-Gonzalez A. DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. PLoS One 2012;7:e29181. [PMID: 22427797 DOI: 10.1371/journal.pone.0029181] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
16 Colvin EK, Susanto JM, Kench JG, Ong VN, Mawson A, Pinese M, Chang DK, Rooman I, O'Toole SA, Segara D, Musgrove EA, Sutherland RL, Apte MV, Scarlett CJ, Biankin AV. Retinoid signaling in pancreatic cancer, injury and regeneration. PLoS One 2011;6:e29075. [PMID: 22220202 DOI: 10.1371/journal.pone.0029075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tsai FM, Wu CC, Shyu RY, Wang CH, Jiang SY. Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth. J Biomed Sci 2011;18:88. [PMID: 22126303 DOI: 10.1186/1423-0127-18-88] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mithani SK, Smith IM, Califano JA. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma. Melanoma Res 2011;21:298-307. [PMID: 21606880 DOI: 10.1097/CMR.0b013e328344a003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
19 Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM. Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action. Dermatoendocrinol 2009;1:100-1. [PMID: 20224692 DOI: 10.4161/derm.1.2.8107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wu CC, Tsai FM, Shyu RY, Tsai YM, Wang CH, Jiang SY. G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. BMC Cancer 2011;11:175. [PMID: 21575264 DOI: 10.1186/1471-2407-11-175] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
21 Dawson MI. Retinoids. Burger's Medicinal Chemistry and Drug Discovery 2010. [DOI: 10.1002/0471266949.bmc065.pub2] [Reference Citation Analysis]
22 Sahab ZJ, Hall MD, Zhang L, Cheema AK, Byers SW. Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26. J Cancer 2010;1:14-22. [PMID: 20842219 DOI: 10.7150/jca.1.14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
23 Candelaria M, de la Cruz-Hernández E, Pérez-Cárdenas E, Trejo-Becerril C, Gutiérrez-Hernández O, Dueñas-González A. Pharmacogenetics and pharmacoepigenetics of gemcitabine. Med Oncol 2010;27:1133-43. [PMID: 19902390 DOI: 10.1007/s12032-009-9349-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
24 Kwok WK, Pang JC, Lo KW, Ng HK. Role of the RARRES1 gene in nasopharyngeal carcinoma. Cancer Genet Cytogenet 2009;194:58-64. [PMID: 19737656 DOI: 10.1016/j.cancergencyto.2009.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
25 Rose MLH, Hincke MT. Protein constituents of the eggshell: eggshell-specific matrix proteins. Cell Mol Life Sci 2009;66:2707-19. [DOI: 10.1007/s00018-009-0046-y] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
26 Vasilatos SN, Broadwater G, Barry WT, Baker JC Jr, Lem S, Dietze EC, Bean GR, Bryson AD, Pilie PG, Goldenberg V, Skaar D, Paisie C, Torres-Hernandez A, Grant TL, Wilke LG, Ibarra-Drendall C, Ostrander JH, D'Amato NC, Zalles C, Jirtle R, Weaver VM, Seewaldt VL. CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiol Biomarkers Prev 2009;18:901-14. [PMID: 19258476 DOI: 10.1158/1055-9965.EPI-08-0875] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
27 Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H, Kitamura S, Nagaya N. Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells. Cell Prolif 2009;42:309-16. [PMID: 19250291 DOI: 10.1111/j.1365-2184.2008.00592.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bonazzi VF, Irwin D, Hayward NK. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 2009;48:10-21. [PMID: 18803327 DOI: 10.1002/gcc.20615] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
29 Kim MS, Chang X, Yamashita K, Nagpal JK, Baek JH, Wu G, Trink B, Ratovitski EA, Mori M, Sidransky D. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 2008;27:3624-3634. [PMID: 18223688 DOI: 10.1038/sj.onc.1211021] [Cited by in Crossref: 114] [Cited by in F6Publishing: 129] [Article Influence: 7.6] [Reference Citation Analysis]
30 Oue N, Yoshida K, Noguchi T, Sentani K, Kikuchi A, Yasui W. Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer. Cancer Sci 2007;98:1198-205. [PMID: 17532757 DOI: 10.1111/j.1349-7006.2007.00515.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
31 Current World Literature. Current Opinion in Oncology 2007;19:65-74. [DOI: 10.1097/cco.0b013e328012d5fa] [Reference Citation Analysis]